Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei. Bai J, Liu F, Yang F, Zhao Y, et al. Vaccine 2023;41:555-563.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bai J, Liu F, Yang F, Zhao Y, et al. Evaluation of transmission-blocking potential of Pv22 using clinical Plasmodium vivax infections and transgenic Plasmodium berghei. Vaccine 2023;41:555-563.
PMID: 36503858